Manavella DD, McNamara B, Harold J, Bellone S, et al. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor. Gynecol Oncol 2022;169:98-105.
PMID: 36525930